MCID: SPN041
MIFTS: 54

Spinal Cord Disease

Categories: Neuronal diseases, Immune diseases, Bone diseases

Aliases & Classifications for Spinal Cord Disease

Summaries for Spinal Cord Disease

MedlinePlus : 40 Your spinal cord is a bundle of nerves that runs down the middle of your back. It carries signals back and forth between your body and your brain. It is protected by your vertebrae, which are the bone disks that make up your spine. If you have an accident that damages the vertebrae or other parts of the spine, this can also injure the spinal cord. Other spinal cord problems include Tumors Infections such as meningitis and polio Inflammatory diseases Autoimmune diseases Degenerative diseases such as amyotrophic lateral sclerosis and spinal muscular atrophy Symptoms vary but might include pain, numbness, loss of sensation and muscle weakness. These symptoms can occur around the spinal cord, and also in other areas such as your arms and legs. Treatments often include medicines and surgery.

MalaCards based summary : Spinal Cord Disease, also known as spinal cord diseases, is related to myelitis and central nervous system disease, and has symptoms including sleeplessness, vertigo/dizziness and hyperexplexia. An important gene associated with Spinal Cord Disease is AQP4 (Aquaporin 4), and among its related pathways/superpathways is Spinal Cord Injury. The drugs Propofol and Sevoflurane have been mentioned in the context of this disorder. Affiliated tissues include spinal cord, bone and brain, and related phenotypes are growth/size/body region and mortality/aging

Wikipedia : 72 Myelopathy describes any neurologic deficit related to the spinal cord. When due to trauma, it is known... more...

Related Diseases for Spinal Cord Disease

Diseases related to Spinal Cord Disease via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 83)
# Related Disease Score Top Affiliating Genes
1 myelitis 31.3 AQP4 MBP MOG TNF
2 central nervous system disease 30.7 AQP4 GDNF MBP MOG SOD1 TNF
3 spinal cord injury 30.0 AQP4 GDNF TNF
4 multiple sclerosis 29.1 AQP4 ERVW-1 MBP MOG TNF
5 vascular myelopathy 12.4
6 myelopathy, htlv-1-associated 12.4
7 htlv-1 associated myelopathy/tropical spastic paraparesis 12.3
8 retrovirus-associated myelopathy 12.1
9 syphilitic myelopathy 12.0
10 tropical spastic paraparesis 11.9
11 spondylosis 11.5
12 foix-alajouanine syndrome 11.2
13 human t-cell leukemia virus type 1 11.2
14 neuroschistosomiasis 11.2
15 ossification of the posterior longitudinal ligament of spine 11.1
16 tethered spinal cord syndrome 11.0
17 sneddon syndrome 10.9
18 meningovascular neurosyphilis 10.5 CD40LG MBP
19 post-vaccinal encephalitis 10.5 CD40LG MBP
20 allergic encephalomyelitis 10.4 MBP MOG
21 neonatal myasthenia gravis 10.4 AQP4 SERPINH1
22 neuroretinitis 10.4 AQP4 CD40LG MOG
23 optic nerve disease 10.4 AQP4 BTD MOG
24 parotid disease 10.4 CD40LG HSF4
25 inappropriate adh syndrome 10.4 AQP4 AVPR2
26 central pontine myelinolysis 10.4 AQP4 MBP
27 balo concentric sclerosis 10.4 AQP4 MBP MOG
28 acute disseminated encephalomyelitis 10.4 AQP4 MBP MOG
29 internuclear ophthalmoplegia 10.3 AQP4 MBP MOG
30 trench fever 10.3 CD40LG TNF
31 neuromyelitis optica 10.3 AQP4 MBP MOG
32 encephalitozoonosis 10.3 CD40LG TNF
33 panencephalitis, subacute sclerosing 10.3 CD40LG MBP MOG
34 miller fisher syndrome 10.3 CD40LG TNF
35 dysgammaglobulinemia 10.3 CD40LG MBP
36 jejunoileitis 10.3 CD40LG GDNF TNF
37 louping ill 10.3 CD40LG ERVW-1
38 encephalomalacia 10.3 AVPR2 MBP SERPINH1
39 rubella 10.2 CD40LG MOG TNF
40 cerebral artery occlusion 10.2 GDNF TNF
41 primary progressive multiple sclerosis 10.2 MBP MOG TNF
42 progressive multifocal leukoencephalopathy 10.2 CD40LG MBP TNF
43 chronic salpingitis 10.2 AVPR2 CD40LG TNF
44 guillain-barre syndrome 10.2 CD40LG MBP TNF
45 anterior spinal artery syndrome 10.2 ADAMTS1 MBP
46 acute vascular insufficiency of intestine 10.2 GDNF SOD1 TNF
47 transient arthritis 10.1 CD40LG ERVW-1 MBP
48 encephalitis 10.1 AQP4 ERVW-1 MOG
49 optic neuritis 10.1 AQP4 MBP MOG TNF
50 neuritis 10.1 AQP4 MBP MOG TNF

Comorbidity relations with Spinal Cord Disease via Phenotypic Disease Network (PDN):


Acute Cystitis Decubitus Ulcer
Deficiency Anemia Hypertension, Essential
Osteoporosis Paraplegia
Prostate Cancer Spinal Stenosis

Graphical network of the top 20 diseases related to Spinal Cord Disease:



Diseases related to Spinal Cord Disease

Symptoms & Phenotypes for Spinal Cord Disease

UMLS symptoms related to Spinal Cord Disease:


sleeplessness, vertigo/dizziness, hyperexplexia, chronic pain, tremor, syncope, seizures, sciatica, pain, myoclonus, hemiplegia, headache, back pain

MGI Mouse Phenotypes related to Spinal Cord Disease:

43
# Description MGI Source Accession Score Top Affiliating Genes
1 growth/size/body region MP:0005378 10.14 ADAMTS1 AQP4 AVPR2 BTD GDNF HBZ
2 mortality/aging MP:0010768 10.1 AQP4 AVPR2 CD40LG GDNF GNB1L HBZ
3 hematopoietic system MP:0005397 10.07 MOG SOD1 TNF AQP4 AVPR2 CD40LG
4 nervous system MP:0003631 9.96 AMPH AQP4 CD40LG GDNF GNB1L MBP
5 renal/urinary system MP:0005367 9.7 ADAMTS1 AQP4 AVPR2 BTD CD40LG GDNF
6 reproductive system MP:0005389 9.56 ADAMTS1 AMPH CD40LG GDNF HBZ MBP
7 vision/eye MP:0005391 9.17 AQP4 BTD HSF4 MBP MOG SOD1

Drugs & Therapeutics for Spinal Cord Disease

Drugs for Spinal Cord Disease (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 585)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Propofol Approved, Investigational, Vet_approved Phase 4 2078-54-8 4943
2
Sevoflurane Approved, Vet_approved Phase 4 28523-86-6 5206
3
Acetylcholine Approved Phase 4,Phase 2,Phase 3 51-84-3 187
4
Lidocaine Approved, Vet_approved Phase 4,Phase 2 137-58-6 3676
5
Pregabalin Approved, Illicit, Investigational Phase 4,Phase 3 148553-50-8 5486971
6
Benzocaine Approved, Investigational Phase 4,Phase 2,Phase 3,Phase 1 1994-09-7, 94-09-7 2337
7
Riluzole Approved, Investigational Phase 4,Phase 2,Phase 3,Phase 1 1744-22-5 5070
8
Dopamine Approved Phase 4,Phase 3,Phase 2,Phase 1 51-61-6, 62-31-7 681
9
Menthol Approved Phase 4,Phase 2,Phase 3,Phase 1 2216-51-5 16666
10
Methylprednisolone Approved, Vet_approved Phase 4,Phase 3,Phase 1,Phase 2,Early Phase 1 83-43-2 6741
11
Prednisolone Approved, Vet_approved Phase 4,Phase 3,Phase 1,Phase 2,Early Phase 1 50-24-8 5755
12
Oxybutynin Approved, Investigational Phase 4,Phase 2 5633-20-5 4634
13
Meloxicam Approved, Vet_approved Phase 4 71125-38-7 54677470 5281106
14
Darifenacin Approved, Investigational Phase 4 133099-04-4 444031
15
Trospium Approved Phase 4,Phase 1 10405-02-4, 47608-32-2 5596 5284631
16
Neostigmine Approved, Vet_approved Phase 4,Phase 1,Early Phase 1 59-99-4 4456
17
Tadalafil Approved, Investigational Phase 4,Phase 3 171596-29-5 110635
18
Carbamazepine Approved, Investigational Phase 4 298-46-4 2554
19
Oxcarbazepine Approved Phase 4 28721-07-5 34312
20 Piracetam Approved, Investigational Phase 4,Phase 3,Phase 2 7491-74-9
21
Amitriptyline Approved Phase 4 50-48-6 2160
22
Perphenazine Approved Phase 4 58-39-9 4748
23
Zoledronic acid Approved Phase 4,Phase 3,Phase 2 118072-93-8 68740
24
Mexiletine Approved, Investigational Phase 4,Phase 2 31828-71-4 4178
25
Neomycin Approved, Vet_approved Phase 4 1404-04-2 8378
26
Phenol Approved, Experimental Phase 4 108-95-2 996
27
Norepinephrine Approved Phase 4,Phase 2 51-41-2 439260
28
Bupropion Approved Phase 4 34911-55-2, 34841-39-9 444
29
Citalopram Approved Phase 4,Phase 3,Phase 1 59729-33-8 2771
30
Zinc Approved, Investigational Phase 4,Phase 3,Phase 1,Phase 2 7440-66-6 32051 23994
31 Zinc sulfate Approved, Investigational Phase 4 7733-02-0
32
Edetic Acid Approved, Vet_approved Phase 4,Phase 3,Phase 2 60-00-4, 62-33-9 6049
33
Iron Approved Phase 4,Phase 3,Phase 2,Phase 1 7439-89-6 23925
34
Teriparatide Approved, Investigational Phase 4,Phase 2 52232-67-4 16133850
35
Goserelin Approved Phase 4 65807-02-5 5311128 47725
36
Mitoxantrone Approved, Investigational Phase 4 65271-80-9 4212
37
Interferon beta-1a Approved, Investigational Phase 4,Phase 2 145258-61-3 6438354
38
Dextromethorphan Approved Phase 4,Phase 3,Phase 2 125-71-3 5362449 5360696
39
Guaifenesin Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 93-14-1 3516
40
Cycloserine Approved Phase 4 68-41-7 6234 401
41
Rivaroxaban Approved Phase 4 366789-02-8
42
Denosumab Approved Phase 4,Phase 2 615258-40-7
43
Trazodone Approved, Investigational Phase 4,Phase 2 19794-93-5 5533
44
Exenatide Approved, Investigational Phase 4 141758-74-9 15991534
45
Vancomycin Approved Phase 4 1404-90-6 14969 441141
46 tannic acid Approved, Nutraceutical Phase 4,Phase 2,Phase 3,Phase 1
47
Vitamin C Approved, Nutraceutical Phase 4 50-81-7 54670067 5785
48
Citric Acid Approved, Nutraceutical, Vet_approved Phase 4,Phase 2 77-92-9 311
49
Melatonin Approved, Nutraceutical, Vet_approved Phase 4 73-31-4 896
50
Folic Acid Approved, Nutraceutical, Vet_approved Phase 4,Phase 2,Phase 3,Phase 1 59-30-3 6037

Interventional clinical trials:

(show top 50) (show all 1704)

# Name Status NCT ID Phase Drugs
1 Anesthesia Induction in Patients Undergoing Surgery for Cervical Myelopathy Unknown status NCT01052337 Phase 4 anaesthetics: sevofluorane
2 Exoskeletons for Spinal Cord Injury: A Feasibility Study Unknown status NCT01943669 Phase 4
3 Eyegaze Systems for Spinal Cord Injury: A Feasibility Study Unknown status NCT01943656 Phase 4
4 Functional Electrical Stimulation-Assisted Walking: Reduction of Secondary Complications Due to Spinal Cord Injury Unknown status NCT00201968 Phase 4
5 Botox for Neurogenic Detrusor Overactivity and the Prevention of Autonomic Dysreflexia Following SCI Unknown status NCT02298660 Phase 4 BOTOX
6 Pregabalin for the Treatment and Prevention of Spinal Cord Injury Neuropathic Pain Unknown status NCT01479556 Phase 4 Pregabalin;Placebo
7 A Study to Evaluate the Efficacy and Safety of Vardenafil in Men With Erectile Dysfunction Caused by Spinal Cord Injury Unknown status NCT00725790 Phase 4 Vardenafil;Placebo
8 Immunogenicity of 1 or 2 Doses of bOPV in Chilean Infants Primed With IPV Vaccine Unknown status NCT01841671 Phase 4
9 Non-Invasive Ventilation in Amyotrophic Lateral Sclerosis Unknown status NCT00560287 Phase 4
10 Clinical Study of Solifenacin Succinate in Patients With Bladder Symptoms Due to Spinal Cord Injury or Multiple Sclerosis Completed NCT00629642 Phase 4 Solifenacin Succinate;Solifenacin Succinate;Oxybutynin Hydrochloride;Placebo
11 Surgical Treatment of Cervical Spondylotic Myelopathy Completed NCT00565734 Phase 4
12 Arthroplasty Versus Fusion in Anterior Cervical Surgery: Prospective Study of the Impact on the Adjacent Level Completed NCT00554528 Phase 4
13 Pregabalin and Radicular Pain Study (PARPS) Completed NCT01061697 Phase 4 Pregabalin
14 Comparative Study of the Efficacy and Safety of Muscarinic M3 Receptors Antagonists in the Treatment of Neurogenic Detrusor Overactivity Completed NCT00800462 Phase 4 Oxybutynin Cl;Trospium Cl;Darifenacin Hydrogen Bromide (HBr)
15 Efficacy and Safety of Standard Oral Colonoscopic Preparations With or Without Neostigmine Compared to Pulse-Irrigation Colonic Lavage Completed NCT00745095 Phase 4 Neostigmine
16 Surgical Versus Nonoperative Treatment of Metastatic Epidural Spinal Cord Compression Completed NCT00634426 Phase 4
17 Effect of Tadalafil (Cialis) on the Cardiovascular System of Spinal Cord Injury (SCI) Males Completed NCT01067391 Phase 4 tadalafil;placebo
18 Symptom Based Treatment of Neuropathic Pain Completed NCT02180880 Phase 4 Pregabalin and Oxcarbazepine
19 Omega-3 Supplementation for Tetraplegics With Poor Cholesterol Levels Completed NCT01896037 Phase 4
20 Neuropathic Pain Study With Botulinum Toxin A in Spinal Cord Injury Patients Completed NCT01579500 Phase 4 Botulinum toxin type A;normal saline
21 Pressure Ulcer Healing With Microcyn Completed NCT02001558 Phase 4 Microcyn
22 Assess Efficacy in Subjects With Traumatic Spinal Cord Injury Completed NCT00667966 Phase 4 Vardenafil (Levitra, BAY 38-9456), 10 mg;Placebo;Vardenafil (Levitra, BAY 38-9456), 20 mg
23 A Study Evaluating the Efficacy and Safety of Sildenafil in Men With Traumatic Spinal Cord Injury and Erectile Dysfunction Completed NCT00654082 Phase 4 sildenafil;placebo
24 Functional Melatonin Replacement for Sleep Disruptions in Individuals With Tetraplegia Completed NCT00507546 Phase 4 Ramelteon;Placebo
25 Investigating Botulinum Toxin A to Treat Acute Neck/Upper Shoulder Pain Following a New Spinal Cord Injury. Completed NCT00320281 Phase 4 botulinum toxin A
26 Treatment of Fecal Incontinence and Constipation in Patients With Spinal Cord Injury Completed NCT00286520 Phase 4
27 Levetiracetam in Chronic Neuropathic Pain Following Spinal Cord Injury Completed NCT00252954 Phase 4 Levetiracetam
28 Chronic Pain in Spinal Cord Injury Completed NCT00006428 Phase 4 Amitriptyline
29 Zoledronic Acid Administration in Acute Spinal Cord Injury Completed NCT02042872 Phase 4 Zoledronic acid
30 Immunogenicity of Monovalent Type 2 Oral Poliovirus Vaccine Completed NCT02643368 Phase 4
31 Mexiletine for the Treatment of Muscle Cramps in ALS Completed NCT01811355 Phase 4 Mexiletine;Placebo
32 A Study to Evaluate the Safety and Immunogenicity of Monovalent OPV2 in Children Aged 1 to 5 Years in Lithuania Completed NCT02582255 Phase 4
33 A Study to Evaluate Safety and Immunogenicity of tOPV in 1 to 5 Years and at 6 Weeks of Age Completed NCT02580201 Phase 4
34 Intestinal and Humoral Immunity of Sequential Polio Vaccination Schedules Completed NCT02412514 Phase 4
35 Myobloc Atrophy Study Completed NCT02052024 Phase 4 Botox;MYOBLOC
36 Polio End-game Strategies - Poliovirus Type 2 Challenge Study Completed NCT02189811 Phase 4
37 Study of IMOVAX POLIO® Subcutaneous as a Booster Vaccine in Pre-school Age Children in Japan Completed NCT02005536 Phase 4
38 IPV Clinical Trial - The Gambia Completed NCT01847872 Phase 4 IPV IM Needle;IPV ID Needle;IPV IM Device;IPV ID Device
39 Feasibility of Telesurveillance and Home Cough Assistance for Amyotrophic Lateral Patients (ALS) Completed NCT00613899 Phase 4
40 Safety and Immunogenicity of 1 or 2 Doses of IPV in Latin American Infants Primed With Bivalent OPV Vaccine Completed NCT01831050 Phase 4
41 Project to Improve Symptoms and Mood in People With Spinal Cord Injury Completed NCT00592384 Phase 4 venlafaxine XR;placebo
42 CARE Canadian ALS Riluzole Evaluation Completed NCT00542412 Phase 4 Riluzole
43 An Objective Double-blind Evaluation of Bupropion and Citalopram in an Individual With Friedreich Ataxia Completed NCT01716221 Phase 4 bupropion & Citalopram;Bupropion & Placebo;Placebo & Citalopram;Placebo & Placebo
44 IPV in Moderate to Severe Chronic Malnourished 9-12 Month Old Children in Karachi. Completed NCT01695798 Phase 4
45 Zinc and/or Probiotic Supplementation of Rotavirus and Oral Polio Virus Vaccines Completed NCT01616693 Phase 4
46 Antibody Persistence to REVAXIS or DT Polio and Immune Response to TETRAVAC-ACELLULAIRE Completed NCT01546909 Phase 4
47 Sequential Inactivated Poliomyelitis Vaccine Followed by Oral Poliomyelitis Vaccine Versus Oral Poliomyelitis Vaccine Completed NCT01475539 Phase 4
48 Comparison of Immunogenicity and Reactogenicity of INFANRIX™ HEXA and HEXAVAC™ Vaccines as a Primary Vaccination Course Completed NCT01457547 Phase 4
49 Regulatory Post-Marketing Surveillance Study for TETRAXIM™ Completed NCT01437423 Phase 4
50 Effect of Parathyroid Hormone (PTH) and Weight-Bearing on Bone in Spinal Cord Injury (SCI) Completed NCT00826228 Phase 4 teriparatide

Search NIH Clinical Center for Spinal Cord Disease

Inferred drug relations via UMLS 69 / NDF-RT 47 :


Cochrane evidence based reviews: spinal cord diseases

Genetic Tests for Spinal Cord Disease

Genetic tests related to Spinal Cord Disease:

# Genetic test Affiliating Genes
1 Myelopathy 28

Anatomical Context for Spinal Cord Disease

MalaCards organs/tissues related to Spinal Cord Disease:

38
Spinal Cord, Bone, Brain, Testes, Bone Marrow, Skin, Colon

Publications for Spinal Cord Disease

Articles related to Spinal Cord Disease:

(show top 50) (show all 76)
# Title Authors Year
1
Prevalence, clinical presentation, prognosis, and outcome of 17 dogs with spinal shock and acute thoracolumbar spinal cord disease. ( 26676985 )
2016
2
Primary central nervous system lymphoma of T-cell origin: an unusual cause of spinal cord disease. ( 27878765 )
2016
3
The intrinsic pathogenic role of autoantibodies to aquaporin 4 mediating spinal cord disease in a rat passive-transfer model. ( 25542977 )
2015
4
Sacral neuromodulation for neurogenic bladder and bowel dysfunction with multiple symptoms secondary to spinal cord disease. ( 25224602 )
2014
5
Autonomic rectal dysfunction in patients with multiple sclerosis and bowel symptoms is secondary to spinal cord disease. ( 24608309 )
2014
6
STIR muscle hyperintensity in the cervical muscles associated with inflammatory spinal cord disease of unknown origin. ( 23458643 )
2013
7
Depression and pain among inpatients with spinal cord injury and spinal cord disease: differences in symptoms and neurological function. ( 23072715 )
2013
8
Positron emission tomography in spinal cord disease. ( 24182699 )
2013
9
Spinal cord disease in patients with cancer. ( 22810129 )
2012
10
Low serum vitamin D levels and recurrent inflammatory spinal cord disease. ( 22083799 )
2012
11
Stress, internal resources and functioning in a person with spinal cord disease. ( 22430577 )
2012
12
Anorectal function and the effect of biofeedback therapy in ambulatory spinal cord disease patients having constipation. ( 20602567 )
2010
13
Characterization of spatiotemporal gait characteristics in clinically normal dogs and dogs with spinal cord disease. ( 19951114 )
2009
14
Surgical management of pressure ulcers during inpatient neurologic rehabilitation: outcomes for patients with spinal cord disease. ( 19569459 )
2009
15
Clinical and magnetic resonance imaging findings in 92 cats with clinical signs of spinal cord disease. ( 18602328 )
2009
16
Rehabilitation outcomes after infection-related spinal cord disease: a retrospective analysis. ( 18356619 )
2008
17
Profound biotinidase deficiency in a child with predominantly spinal cord disease. ( 18645204 )
2008
18
Signs of spinal cord disease in two heifers caused by Listeria monocytogenes. ( 14758832 )
2004
19
From the electrodiagnosis lab...H-reflexes in hand muscles after cervical spinal cord disease. ( 14598812 )
2003
20
Spinal cord disease in West Nile virus infection. ( 12575663 )
2003
21
Spinal cord disease in West Nile virus infection. ( 12571269 )
2003
22
Electrophysiological evaluation of root and spinal cord disease. ( 12524565 )
2002
23
The use of magnetic motor evoked potentials in horses with cervical spinal cord disease. ( 11902758 )
2002
24
Botulinum a toxin and detrusor sphincter dyssynergia: a double-blind lidocaine-controlled study in 13 patients with spinal cord disease. ( 12121731 )
2002
25
Correlation between severity of clinical signs and motor evoked potentials after transcranial magnetic stimulation in large-breed dogs with cervical spinal cord disease. ( 12420825 )
2002
26
Spinal cord disease due to melioidosis. ( 10450444 )
1999
27
Intrathecal baclofen therapy for spinal origin spasticity: spinal cord injury, spinal cord disease, and multiple sclerosis. ( 22151114 )
1999
28
Botulinum A toxin treatment for detrusor-sphincter dyssynergia in spinal cord disease. ( 9494997 )
1998
29
The effects of capsaicin on the neurogenic hyperreflexic detrusor. A double blind placebo controlled study in patients with spinal cord disease. Preliminary results. ( 9494998 )
1998
30
Vertebrospinal angiography in the evaluation of vertebral and spinal cord disease. ( 8873094 )
1996
31
Chemosensitive epidural spinal cord disease in non-Hodgkins lymphoma. ( 8649545 )
1996
32
Spinal cord disease due to vacuolar myelopathy in AIDS. ( 8039791 )
1994
33
Spontaneous ejaculation secondary to spinal cord disease. ( 8164008 )
1994
34
Somatosensory potentials in dogs with naturally acquired thoracolumbar spinal cord disease. ( 8291776 )
1993
35
Congenital, hereditary and developmental spinal cord disease. ( 1325226 )
1992
36
Management of bowel dysfunction in children with spinal cord disease or injury by means of the enema continence catheter. ( 1735813 )
1992
37
Repair and regeneration: experimental aspects of spinal cord disease. ( 1515695 )
1992
38
The diagnostic impact of magnetic resonance imaging on the evaluation of suspected spinal cord disease. ( 1441553 )
1992
39
Disorders of bladder function in spinal cord disease. ( 1921955 )
1991
40
Rehabilitation of patients with spinal cord disease. ( 1921954 )
1991
41
Disturbed sexual function in patients with spinal cord disease. ( 1921957 )
1991
42
Medical complications of spinal cord disease. ( 1921958 )
1991
43
Spinal cord disease in children with HIV-1 infection: a combined molecular biological and neuropathological study. ( 2234312 )
1990
44
Cervical spine: MR imaging with a partial flip angle, gradient-refocused pulse sequence. Part II. Spinal cord disease. ( 3336723 )
1988
45
Cerebrospinal fluid immunoreactive substance P and somatostatin in neurological patients with peripheral and spinal cord disease. ( 2468107 )
1988
46
Medical management of spinal cord disease. ( 3113696 )
1987
47
Spinal-evoked potentials in dogs with acute compressive thoracolumbar spinal cord disease. ( 3674565 )
1987
48
The value of paraxial slices in MR-imaging of spinal cord disease. ( 3762914 )
1986
49
Magnetic resonance imaging of spinal cord disease of childhood. ( 3737301 )
1986
50
Incidence, presentation, and outcome of spinal cord disease in children with systemic cancer. ( 3748677 )
1986

Variations for Spinal Cord Disease

Expression for Spinal Cord Disease

Search GEO for disease gene expression data for Spinal Cord Disease.

Pathways for Spinal Cord Disease

Pathways related to Spinal Cord Disease according to GeneCards Suite gene sharing:

# Super pathways Score Top Affiliating Genes
1 11 AQP4 GDNF MBP TNF

GO Terms for Spinal Cord Disease

Biological processes related to Spinal Cord Disease according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 membrane organization GO:0061024 9.33 AMPH AVPR2 MBP
2 central nervous system development GO:0007417 9.13 BTD MBP MOG
3 regulation of immunoglobulin secretion GO:0051023 8.62 CD40LG TNF

Sources for Spinal Cord Disease

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
27 GO
28 GTR
29 HGMD
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 MedGen
41 MeSH
42 MESH via Orphanet
43 MGI
45 NCI
46 NCIt
47 NDF-RT
50 NINDS
51 Novoseek
53 OMIM
54 OMIM via Orphanet
58 PubMed
60 QIAGEN
65 SNOMED-CT via HPO
66 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....